Table 2.

Treatment efficacy in patients (N = 17)

Treatment efficacy	No. of patients	%
Response
Overall response rate	13	76.4
Disease control rate	15	88.2
Complete response	1	5.9
Partial response	12	70.6
Stable disease	2	11.7
Progressive disease	2	11.7
Survival
Median PFS (months)	10.0 (95 % CI: 7.6–12.3 months)
Median OS (months)	14.0 (95 % CI: 10.7–17.2 months)